Infectious Diseases Society of America

Five pharmacy regulations health execs must keep on their radars in 2017Here are five critical regulations that executives can begin to prepare for today.
New hep C guidelines endorse direct-acting anti-viral agentsNearly all patients with chronic hepatitis C virus (HCV) infections should receive direct-acting anti-viral agents, according to updated guidelines by the American Association for the Study for Liver Diseases and the Infectious Diseases Society of America.
Beta-lactam or macrolide monotherapy for CAP?Empiric beta-lactam and macrolide monotherapy are similarly effective in outpatient management of children with community-acquired pneumonia (CAP), according to results of a multicenter retrospective study in 1164 children treated for CAP at primary care pediatric clinics in Pennsylvania.
The 5 most over-prescribed antibioticsBecause of overuse and misuse, some antibiotics are losing effectiveness against highly resistant bacteria.
Emerging multidrug-resistant H58 typhoid strain highlights need for antibiotic stewardshipA large international study, published in Nature Genetics, found that the H58 “superbug” version, which is resistant to multiple types of antibiotics, is now a major global health threat affecting many countries, including Asia and Africa, where typhoid is endemic.
[BLOG]: Providers and payers share responsibility in making antimicrobial stewardship programs a priority
[BLOG]: Providers and payers share responsibility in making antimicrobial stewardship programs a priorityThe number of antibiotic-resistant strains continues to rise rapidly. Statistics from the Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) point to alarming trends that are exacerbated by fewer new antibiotics coming into the market and high costs.
Guideline: Patients with liver disease should be first to receive expensive Hep C drugsPatients with advanced liver disease or other severe symptoms of hepatitis C virus (HCV) infection should be first in line for drug therapy, according to a new guideline from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America.
Skin abscesses with MRSA: How to manageIt has been more than a decade since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and physicians are still trying to figure out how to diagnose, treat, and prevent this virulent form of staph infection, which is immune to many antibiotics.
Narrow-spectrum and broad-spectrum antibiotics effective for inpatient pneumoniaInvestigators compared outcomes in hospitalized children with community-acquired pneumonia who were treated with a narrow-spectrum antibiotic (ampicillin/penicillin) versus a broad-spectrum agent (ceftriaxone/cefotaxime), each by a parenteral route.
Narrow versus broad antibiotics for pneumoniaAlthough little difference exists in outcomes between broad-spectrum and narrow-spectrum antibiotics for children hospitalized with community-acquired pneumonia (CAP), narrow-spectrum agents are associated with a shorter hospital stay, according to a recent study, and, not incidentally, help to minimize the problem of antibiotic resistance.